Selected article for: "chronic disease and long term"
Author: Abate, Giulia; Memo, Maurizio; Uberti, Daniela
Title: Impact of COVID-19 on Alzheimer’s Disease Risk: Viewpoint for Research Action
  • Cord-id: 4qmajxtb
  • Document date: 2020_8_21
    • ID: 4qmajxtb
    Snippet: In the middle of the coronavirus disease 19 (COVID-19) outbreak, the main efforts of the scientific community are rightly all focused on identifying efficient pharmacological treatments to cure the acute severe symptoms and developing a reliable vaccine. On the other hand, we cannot exclude that, in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) positive subjects, the virus infection could have long-term consequences, leading to chronic medical conditions such as dementia and neuro
    Document: In the middle of the coronavirus disease 19 (COVID-19) outbreak, the main efforts of the scientific community are rightly all focused on identifying efficient pharmacological treatments to cure the acute severe symptoms and developing a reliable vaccine. On the other hand, we cannot exclude that, in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) positive subjects, the virus infection could have long-term consequences, leading to chronic medical conditions such as dementia and neurodegenerative disease. Considering the age of SARS-CoV-2 infected subjects, the neuroinvasive potential might lead/contribute to the development of neurodegenerative diseases. Here, we analyzed a possible link between SARS-CoV-2 infection and Alzheimer’s disease risk, hypothesizing possible mechanisms at the base of disease development. This reflection raises the need to start to experimentally investigating today the mechanistic link between Alzheimer’s disease (AD) and COVID-19 to be ready tomorrow.

    Search related documents:
    Co phrase search for related documents
    • ace1 activity and acute respiratory distress syndrome: 1
    • ace1 activity and acute respiratory syndrome: 1, 2, 3
    • ace1 activity and acute respiratory syndrome coronavirus: 1, 2
    • action mechanism and acute respiratory: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • action mechanism and acute respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
    • action mechanism and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • action mechanism and acute respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • action mechanism and ad development: 1, 2
    • action plan and acute respiratory: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • action plan and acute respiratory distress syndrome: 1, 2, 3
    • action plan and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • action plan and acute respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7
    • activate microglia and acute respiratory: 1
    • activate microglia and acute respiratory syndrome: 1
    • activate microglia and acute respiratory syndrome coronavirus: 1
    • activate microglia and ad alzheimer disease: 1
    • activate microglia and ad development: 1
    • acute respiratory and ad context: 1, 2
    • acute respiratory and ad development: 1, 2, 3